A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

Sharad Ghamande, Chia Chi Lin, Daniel C. Cho, Geoffrey I. Shapiro, Eunice L. Kwak, Michael H. Silverman, Yunlong Tseng, Min Wen Kuo, Wendy B. Mach, Shu Chi Hsu, Teresa Coleman, James Chih Hsin Yang, Ann Lii Cheng, Mohammad H. Ghalib, Imran Chuadhary, Sanjay Goel

Research output: Contribution to journalArticle

13 Scopus citations

Fingerprint Dive into the research topics of 'A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences